Jerrold Duane Dotson

Jerrold Duane Dotson discloses dealings in VistaGen Therapeutics, Inc. to SEC (Form 4). We count 9 filings; the first trade dates from 30 June 2020 and the latest from 30 June 2023.

Every open-market trade on record is a sale: 1 sale worth €79k. Outside the open market, there are 7 share grants and 1 option exercise.

On 5 July 2023 came the latest disclosure, a share grant for €244 in VistaGen Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.